•
Dec 31, 2018

Voyager Therapeutics Q4 2018 Earnings Report

Total Revenue
$2.01M
Previous year: $6.35M
-68.4%
EPS
-$0.7
Previous year: -$0.4
+75.0%
Gross Profit
-$14.9M
Cash and Equivalents
$46.9M
Free Cash Flow
-$24.9M
Total Assets
$177M

Voyager Therapeutics

Voyager Therapeutics